IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 43 filers reported holding IKENA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,262,024 | -24.7% | 1,446,195 | +14.1% | 0.00% | – |
| Q2 2023 | $8,313,770 | +684.4% | 1,267,343 | +312.5% | 0.00% | – |
| Q1 2023 | $1,059,956 | +30.5% | 307,234 | +0.6% | 0.00% | – |
| Q4 2022 | $812,406 | -54.4% | 305,416 | -39.2% | 0.00% | – |
| Q3 2022 | $1,783,000 | +39.8% | 502,152 | +74.5% | 0.00% | – |
| Q2 2022 | $1,275,000 | -86.0% | 287,748 | -80.7% | 0.00% | – |
| Q1 2022 | $9,108,000 | -46.7% | 1,493,161 | +9.5% | 0.00% | – |
| Q4 2021 | $17,102,000 | +180.0% | 1,363,877 | +181.8% | 0.00% | – |
| Q3 2021 | $6,107,000 | -3.3% | 483,931 | +7.6% | 0.00% | – |
| Q2 2021 | $6,314,000 | +156.8% | 449,738 | +416.8% | 0.00% | – |
| Q1 2021 | $2,459,000 | – | 87,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |